Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

ChemioCare planning to IPO and raise funds to bring ‘transformative’ drug to the market

Thursday, May 17, 2018 11:09
% of readers think this story is Fact. Add your two cents.

ChemioCare CEO Pedro Lichtinger tells Proactive Investors the bio-pharmaceutical company is focused on treating the side effects of chemotherapy.

Founded around one year ago, Lichtinger says the company’s transdermal patch technology will help cancer patients going through chemotherapy to experience significantly less side effects of the drug including less nausea and vomiting.

Lichtinger says the company is planning to go public and list on the Nasdaq and the TSX in around 10 months, using the capital raised to run the clinical trials for the drug.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.